TSS
TARA icon

Two Sigma Securities’s Protara Therapeutics TARA Stock Holding History

Two Sigma Securities’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,393
Closed -$69.7K – 3655
2024
Q1 		$69.7K Buy
+17,393
New +$56.1K ﹤0.01% 2525
2019
Q2 		– Sell
-1,270
Closed -$26K – 2407
2019
Q1 		$26K Buy
+1,270
New +$145K ﹤0.01% 1654

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Two Sigma Securities's TARA Position: Q2 2024 in Review

Two Sigma Securities sold out of Protara Therapeutics (TARA) in Q2 2024, closing a stake of 17,393 shares — an estimated $69.7K sold.

Two Sigma Securities first reported a position in TARA in Q1 2019 and held it in 2 quarters. The position peaked at $69.7K in Q1 2024. 38 funds tracked by Wall St. Rank hold TARA as of Q2 2024.

  • Two Sigma Securities reported no remaining Protara Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 17,393 Protara Therapeutics shares in Q2 2024, an estimated $69.7K.
  • Two Sigma Securities first reported a position in Protara Therapeutics in Q1 2019 and held it in 2 quarters.
  • Two Sigma Securities's Protara Therapeutics position peaked at $69.7K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.